Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB-Related Articles

Journal Articles Published by Division of TB Elimination (DTBE) Authors

2010 DTBE Journal Articles


Aburto NJ, Pevzner E, Lopez-Ridaura R, Rojas R, Lopez-Gatell H, Lazcano E, Hernandez-Avila M, Harrington TA. Knowledge and adoption of community mitigation efforts in Mexico during the 2009 H1N1 pandemic. Am J Prev Med 2010 Nov;39(5):395-402.

Agizew TB, Arwady MA, Yoon JC, Nyirenda S, Mosimaneotsile B, Tedla Z, Motsamai O, Kilmarx PH, Wells CD, Samandari T. Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention. Int J Tuberc Lung Dis 2010 Jan; 14 (1): 45-51.

Agizew T, Bachhuber MA, Nyirenda S, Makwaruzi VZ, Tedla Z, Tallaksen RJ, Parker JE, Mboya JJ, Samandari T. Association of chest radiographic abnormalities with tuberculosis disease in asymptomatic HIV-infected adults. Int J Tuberc Lung Dis 2010 March; 14(3): 324-331.

Anger HA, Dworkin F, Sharma S, Munsiff SS, Nilsen DM, Ahuja SD. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. J Antimicrobial Chemotherapy 2010 April; 65(4): 775-783.

Anekvorapong R, Sinthuwattanawibool C, Podewils L, McCarthy K, Ngamlert K, Promsarin B, Varma JK. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infectious Diseases 2010:123.

Anuwatnonthakate A, Jittimanee SX, Cain J, Nateniyom S, Wattanaamornkiat W, Komsakorn S, Moolphate S, Banyati P, Chiengsorn N, Limsomboon P, Kaewsa-Ard S, Varma JK. Barriers to human immunodeficiency virus testing of tuberculosis patients in Thailand, 2004-2007. Int J Tuberc Lung Dis 2010 Aug;14(8):980-5.

Beavers SF, Holtz TH, Garrett DO. Hospital-based surveillance for DR-TB: necessary but not sufficient. [Editorial.] Int J Tuberc Lung Dis 2010 Jan; 14(1):5.

Blaya JA, Shin SS, Yale G, Suarez C, Asencios L, Contreras C, Rodriguez P, Kim J, Cegielski P, Fraser HSF. Electronic laboratory system reduces errors in National Tuberculosis Program: a cluster randomized controlled trial. Int J Tuberc Lung Dis 2010 Aug; 14 (8): 1009-1015.

Bloss E, Kukša L, Holtz TH, Riekstina V, Skripčonoka V, Kammerer S, Leimane V. Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000–2004. Int J Tuberc Lung Dis 2010 March: 14(3): 275-281.

Buff AM, Moonan PK, Desai MA, McKenna TL, Harris DA, Rogers BJ, Rabley SS, Oeltmann JE. South Carolina tuberculosis genotype cluster investigation: a tale of substance abuse and recurrent disease. [Notes from the field.] Int J Tuberc Lung Dis 2010 Oct; 14(10): 1347-1349.

Cain KP, McCarthy KD, Heilig CM, Monkongdee P, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010 Feb 25; 362:707-716.

Cain KP, Nelson LJ, Cegielski JP. Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2010 March; 14(3): 269-274.

Castro KG, Bell BP, Schuchat A. Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung [Editorial. 2010: The Year of the Lung. Series editor: John F. Murray.] Int J Tuberc Lung Dis 2010 Feb; 14 (2): 127-129.

Cegielski P. Extensively drug-resistant tuberculosis: “There must be some kind of way out of here.” Clin Infect Dis 2010 May 15; 50 Suppl 3: S195-200.

Chauhan LS, Wares F, Sahu S, Dewan P, Chadha S, Thirumala A, Ramachandran R. Drug resistance in Kerala. [Correspondence.] Int J Tuberc Lung Dis 2010 May; 14(5): 660-661.

Courter JD, Girotto JE, Lobato MN, Orcutt D, Burke M, Feder HM, Jr., Krause PJ, Cohen-Abbo A, Salazar JC. Intravenous streptomycin for treatment of Mycobacterium tuberculosis meningitis in an infant. Pharmacotherapy 2010;30(11):481e–484e.

De Kantor IN, LoBue PA, Thoen CO. Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America, and the Caribbean. Int J Tuberc Lung Dis 2010 Nov;14(11):1369-73.

Dewan PK, Gupta D, Williams BG, Thakur R, Bachani D, Khera A, Wares DF, Sahu S, Reddy DCS, Raizada N Chauhan LS. National estimate of HIV seroprevalence among tuberculosis patients in India. [Short communication.] Int J Tuberc Lung Dis 2010 Feb; 14(2):247-9.

Goldberg S, LoBue P. Pulmonary tuberculosis: focus on the fluoroquinolones. Clinical Medicine Insights: Therapeutics 2010;2: 341–352

Griffiths G, Nyström B, Sable SB, Khuller GK. Nanobead-based interventions for the treatment and prevention of tuberculosis. Nature Reviews Microbiology 2010 Nov; 8(11): 827-34.

Harris TG, Li J, Hanna DB, Munsiff SS. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005. Clin Infect Dis 2010 Jun 1; 50(11): 1524-31.

Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P, and the Tuberculosis Epidemiologic Studies Consortium. Latent tuberculosis infection treatment acceptance and completion in the United States and Canada. Chest 2010 Feb; 137(2): 401-9.

Kane S, Dewan PK, Gupta D, Wi T, Das A, Singh A, Bitra G, Chauhan LS, Dallabetta G. Large-scale public-private partnership for improving TB-HIV services for high-risk groups in India. [Notes from the Field.] Int J Tuberc Lung Dis 2010 Aug; 14(8):1066–1068.

King L, Munsiff SS, Ahuja SD. Achieving international targets for tuberculosis treatment success among HIV-positive patients in New York City. Int J Tuberc Lung Dis 2010 Dec; 14(12): 1613-1620.

Kornylo-Duong K, Kim C, Cramer EH, Buff AM, Rodriguez-Howell D, Doyle J, Higashi J, Fruthaler CS, Robertson CL, Marienau KJ. Three air travel-related contact investigations associated with infectious tuberculosis, 2007–2008. Travel Medicine and Infectious Disease 2010 March; 8(2): 120-128.

Lazar CM, Sosa L, Lobato MN. Practices and policies of providers testing school-aged children for tuberculosis, Connecticut, 2008. J Community Health 2010; 35:495–499.

Leimane V, Dravniece G, Riekstina V, Sture I, Kammerer S, Chen MP, Skenders G, Holtz TH. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 2010; 36: 584–593.

Leinhardt C, Vernon A, Raviglione MC. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes. Current Opinion in Pulmonary Medicine 2010 May; 16(3): 186-193.

Lewinsohn DA, Lobato MN, Jereb JA. Interferon-[gamma] release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Current Opinion in Pediatrics 2010 Feb; 22(1): 71-76.

Li J, Munsiff SS, Agerton TB. Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health 2010 Dec;12(6):816-822.

Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis 2010 Apr;14(4):e292-7.

LoBue PA, Enarson DA, Thoen CO. Tuberculosis in humans and animals: an overview. [Serialised article. Tuberculosis: a re-emerging disease in animals and humans. Number 1 in the series]. Int J Tuberc Lung Dis 2010 Sept; 14(9): 1075-1078.

LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. [Serialised article. Tuberculosis: a re-emerging disease in animals and humans. Number 2 in the series]. Int J Tuberc Lung Dis 2010 Oct; 14(10): 1226-1232.

LoBue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology 2010 May; 15(4): 603-622.

Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375:1814-1829.

Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiology 2010 Feb; 39(1): 149-155.

Marienau KJ, Burgess GW, Cramer E, Averhoff FM, Buff AM, Russell M, Kim C, Neatherlin JC, Lipman H. Tuberculosis investigations associated with air travel: U. S. Centers for Disease Control and Prevention, January 2007–June 2008. Travel Medicine and Infectious Disease 2010 March; 8 (2): 104-112.

Menzies HJ, Winston CA, Holtz TH, Cain KP, Mac Kenzie WR. Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994–2007. Am J Public Health July 15, 2010. [Epub ahead of print.]

Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell PC, Kawamura LM, Nahid P. Evaluation of quantitative IFN-{gamma} response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med 2010;181:87-93.

Miner MC, Burns-Grant G, DeGraw C, Wallace C, Pozsic C, Jereb J. Integrated preparedness for continuity of tuberculosis care After hurricanes Gustav and Ike: Louisiana and Texas, 2008. Public Health Reports 2010 July-Aug; 25: 518-19.

Miramontes R, Lambert L, Haddad MB, Boaz V, Hawkins S, Zylstra M, Allen R, Rivers S, Ali B, Chewning SS, Holt E, Warkentin J. Public health response to a multidrug-resistant tuberculosis outbreak among Guatemalans in Tennessee, 2007. South Med J 2010 Sep;103(9):882-6.

Mosimaneotsile B, Mathoma A, Chengeta B, Nyirenda S, Agizew T, Tedla Z, Motsamai O, Kilmarx PH, Wells CD, Samandari T. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana experience, 2004-2006. JAIDS 2010 May 1; 54(1): 71-77.

Nabbuye-Sekandi J, Okot-Chono R, Rusen ID, Dlodlo RA, Katamba A, Tumwesigye NM, Fujiwara PI. Factors associated with human immunodeficiency virus testing among tuberculosis patients receiving treatment at health facilities in Uganda. Int J Tuberc Lung Dis 2010 July; 14(7): 896-902.

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; for the Tuberculosis Trials Consortium. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One 2010 May 20;5(5):e10753.

Ohkado A, Pevzner E, Sugiyama T, Murakami K, Yamada N, Cavanaugh S, Ishikawa N, Harries AD. Evaluation of an international training course to build programmatic capacity for tuberculosis control. [Short communication.] Int J Tuberc Lung Dis 2010 March; 14(3): 371-373.

Pai M, Castro K, Mori T, Lienhardt C. Proceedings of the Second Global Symposium on Interferon-Gamma Release Assays. Session 9, Guidelines. Int J Tuberc Lung Dis 2010 June Suppl 1; 14: S64-S69.

Parvez F, Lobato MN, Greifinger R. TB control: a prevention model for outbreak preparedness in correctional facilities. [Commentary.] J Correct Health Care 2010; 16:239-242.

Pevzner ES, Robison S, Donovan J, Allis D, Spitters C, Friedman R, Ijaz K, Oeltmann JE. Tuberculosis transmission and use of methamphetamines in Snohomish County, WA, 1991-2006. Am J Public Health 2010 Dec;100(12):2481-6. Epub 2010 Feb 18.

Podewils LJ, Holtz T, Riekstina V, Skripconoka V, Zarovska E, Kirvelaite G, Kreigere E, Leimane V. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect 2010 Apr 30:1-8.

Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE. Rapid detection of multidrug resistant tuberculosis using real-time PCR and high resolution melt analysis. J Clin Microbiol 2010 Sep 1. [Epub ahead of print.]

Rodwell TC, Barnes RFW, Moore M, Strathdee SA, Raich A, Moser KS, Garfein RS. HIV-tuberculosis coinfection in southern California: evaluating disparities in disease burden. Am J Public Health 2010 April; 100 Suppl 1: S178-S185.

Sabharwal CJ, Muse KH, Alper H, Begier E, McNeill M, Galeta G, Huang K, Franklin W, Parvez F. Jail-based providers’ perceptions of challenges to routine HIV testing in New York City jails. Journal of Correctional Health Care 2010; 16(4): 310-321.

Samandari T, Bishai D, Luteijn M, Mosimaneotsile B, et al. Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana. Am J Respir Crit Care Med 2010 Dec 10. [Epub ahead of print.]

Schecter GF, Scott C, True L, Raftery A, Flood J, and Mase S. Linezolid in the treatment of multidrug–resistant tuberculosis. Clin Infect Dis 2010 Jan 1; 50 (1):49–55.

Sculier D, Vannarith C, Reaksmey P, Thai S, Kanara N, Borann S, Cain KP, Lynen L, Varma JK. Performance of abdominal ultrasound for diagnosis of tuberculosis in HIV-infected persons living in Cambodia. J Acquir Immune Defic Syndr. 2010;55:500-2.

Silin M, Laraque F, Munsiff SS, Crossa A, Harris TG. The impact of monitoring tuberculosis reporting delays in New York City. J Public Health Manag Pract 2010 Sep-Oct;16(5):E09-17.

Tedla Z, Nyirenda S, Peeler C, Agizew T, Sibanda T, Motsamai O, Vernon A, Wells CD, and Samandari T. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in HIV-infected adults in Botswana. Am J Respir Crit Care Med 2010; 182: 278-285.

Thoen CO, LoBue PA, de Kantor I. Why has zoonotic tuberculosis not received much attention? [Editorial.] Int J Tuberc Lung Dis 2010 Sept; 14(9):1073–1074.

Thomas JA, Laraque F, Munsiff S, Piatek A, Harris TG. Hospitalizations for tuberculosis in New York City: how many could be avoided? Int J Tuberc Lung Dis 2010 Dec; 14(12): 1603–1612.

Varma JK, McCarthy KD, Tasaneeyapan T, Monkongdee P, Kimerling M, Buntheon E, Sculier D, Keo C, Phanuphak P, Teeratakulpisarn N, Udomsantisuk N, Dung NH, Lan NTN, Yen NTB, Cain KP. Bloodstream infections among HIV-infected outpatients, Southeast Asia. Emerg Infect Dis 2010;16:1569-1575.

Vernon A. A trial involving HIV-tuberculosis in India: the minute particulars. Am J Respir Crit Care Med 2010; 181:652-4.

Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ 2010 Sept 7. [Epub ahead of print.]

Weiner M, Peloquin C, Burman W, Luo CC, Engle M, Prihoda TJ, Mac Kenzie WR, Bliven-Sizemore E, Johnson JL, Vernon A. The effects of tuberculosis, race and human gene SLCO1B1 polymorphisms on rifampin concentrations. Antimicrob Agents Chemother 2010 Jul 26. [Epub ahead of print].

Weiner M, Prihoda TJ, Burman W, Johnson JL, Goldberg S, Padayatchi N, Duran P, Engle M, Muzanye G, Mugerwa RD, Sturm AW. Evaluation of time to detection in broth culture as an endpoint for tuberculosis trials. J Clin Microbiol 2010 Oct 6. [Epub ahead of print].

Winston C, Navin T. Birth cohort effect on latent tuberculosis infection prevalence, United States. BMC Infectious Diseases 2010; 10:206.

Winters A, Agerton TB, Driver CR, Trieu L, O'Flaherty T, Munsiff SS. Congenital tuberculosis and management of exposure in three neonatal intensive care units. [Case study.] Int J Tuberc Lung Dis 2010 Dec; 14 (12): 1641-1643.

Wongsrichanalai C, Varma JK, Juliano JJ, Kimerling ME, MacArthur JR. Extensive drug resistance in malaria and tuberculosis. Emerg Infect Dis [online]. 2010 Jul. Accessed at http://www.cdc.gov/EID/content/16/7/1063.htm

 
Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #